Detalles de la búsqueda
1.
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction.
Kidney Int
; 104(4): 840-850, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37391040
2.
Surrogate Endpoints for Late Kidney Transplantation Failure.
Transpl Int
; 35: 10136, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35669974
3.
Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation.
Transpl Int
; 35: 10139, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35669976
4.
Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation.
Transpl Int
; 35: 10137, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35669977
5.
Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe.
Transpl Int
; 35: 10225, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36017158
6.
Dual Costimulatory and Coinhibitory Targeting with a Hybrid Fusion Protein as an Immunomodulatory Therapy in Lupus Nephritis Mice Models.
Int J Mol Sci
; 23(15)2022 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35955542
7.
Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial.
Am J Transplant
; 21(8): 2833-2845, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33725408
8.
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.
Lancet
; 395(10237): 1627-1639, 2020 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32446407
9.
Adoption of a novel smart mobile-health application technology to track chronic immunosuppression adherence in solid organ transplantation: Results of a prospective, observational, multicentre, pilot study.
Clin Transplant
; 35(5): e14278, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33682207
10.
Functional immune monitoring of BK Virus and donor-specific T-cell effector immune responses to guide treatment decision-making after kidney transplantation; an illustrative case report and literature review.
Transpl Infect Dis
; 23(2): e13495, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33070461
11.
Dual and Opposite Costimulatory Targeting with a Novel Human Fusion Recombinant Protein Effectively Prevents Renal Warm Ischemia Reperfusion Injury and Allograft Rejection in Murine Models.
Int J Mol Sci
; 22(3)2021 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33530581
12.
Cellular Immunity to Predict the Risk of Cytomegalovirus Infection in Kidney Transplantation: A Prospective, Interventional, Multicenter Clinical Trial.
Clin Infect Dis
; 71(9): 2375-2385, 2020 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32076718
13.
Noncanonical immunomodulatory activity of complement regulator C4BP(ß-) limits the development of lupus nephritis.
Kidney Int
; 97(3): 551-566, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31982108
14.
Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies.
Am J Transplant
; 19(10): 2865-2875, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31012541
15.
Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation.
Am J Transplant
; 19(2): 368-380, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30085394
16.
Open letter to Bristol Myers Squibb: Belatacept; we aren't done yet.
Am J Transplant
; 23(10): 1483-1484, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37394381
17.
ANRIL as a genetic marker for cardiovascular events in renal transplant patients - an observational follow-up cohort study.
Transpl Int
; 2018 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29722077
18.
The Costimulatory Pathways and T Regulatory Cells in Ischemia-Reperfusion Injury: A Strong Arm in the Inflammatory Response?
Int J Mol Sci
; 19(5)2018 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29693595
19.
Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
Kidney Int
; 92(1): 201-213, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28274484
20.
The combination of CYP3A4*22 and CYP3A5*3 single-nucleotide polymorphisms determines tacrolimus dose requirement after kidney transplantation.
Pharmacogenet Genomics
; 27(9): 313-322, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28704257